Mucus Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Mucus Relief
Generic name: GUAIFENESIN
Manufacturer: Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
Product type: HUMAN OTC DRUG
SPL set ID: 32f58b4a-3e1b-424f-8296-a9bf9a7d7025
SPL ID: 2f49161f-a4cf-4b5c-bc7d-dace78ee58e8
Version: 5
Effective date: 2025-11-11
Source export date: 2026-09-28
Source partition: 5
Source file: https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9839785a692b692224cd5f90f9e3a9514c9923a6f521ab83eed3bedc7c0e1d05/drug-label-0005-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:34:15

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	207342	derived:openfda.application_number
application number		ANDA207342	openfda.application_number
brand name		Mucus Relief	openfda.brand_name
generic name		GUAIFENESIN	openfda.generic_name
manufacturer name		Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)	openfda.manufacturer_name
ndc	package	55910-739-20	openfda.package_ndc
ndc	product	55910-739	openfda.product_ndc
ndc11	package	55910073920	derived:openfda.package_ndc
rxcui		636522	openfda.rxcui
spl id		2f49161f-a4cf-4b5c-bc7d-dace78ee58e8	id
spl set id		32f58b4a-3e1b-424f-8296-a9bf9a7d7025	set_id
unii		495W7451VQ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use for children under 12 years of age. Ask a doctor before use if you have persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis or emphysema cough accompanied by too much phlegm (mucus) Stop use and ask a doctor if cough lasts more than 7 days, comes back, or occurs with fever, rash or persistent headache. These could be signs of a serious illness. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.